Literature DB >> 17999626

Iron homeostasis in the lung following asbestos exposure.

Andrew J Ghio, Jacqueline Stonehuerner, Judy Richards, Robert B Devlin.   

Abstract

Human exposure to asbestos can cause a wide variety of pulmonary diseases, including pneumoconiosis (i.e., asbestosis). This lung injury is mediated by oxidant generation which increases with the concentration of iron associated with the asbestos. Iron from host sources is complexed by the surface of these fibrous silicates following introduction into the lower respiratory tract. Using bronchoalveolar lavage from unexposed and exposed workers, we demonstrate that asbestos disrupts the normal iron homeostasis in the lungs. Based on these findings, we propose a model of oxidative stress and human lung injury after asbestos exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17999626     DOI: 10.1089/ars.2007.1909

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  19 in total

1.  Mouse serum exosomal proteomic signature in response to asbestos exposure.

Authors:  Phillip Munson; Ying-Wai Lam; Maximilian MacPherson; Stacie Beuschel; Arti Shukla
Journal:  J Cell Biochem       Date:  2018-04-16       Impact factor: 4.429

Review 2.  Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.

Authors:  Sarah X L Huang; Marie-Claude Jaurand; David W Kamp; John Whysner; Tom K Hei
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

Review 3.  Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.

Authors:  Brooke T Mossman; Morton Lippmann; Thomas W Hesterberg; Karl T Kelsey; Aaron Barchowsky; James C Bonner
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

Review 4.  Molecular basis of asbestos-induced lung disease.

Authors:  Gang Liu; Paul Cheresh; David W Kamp
Journal:  Annu Rev Pathol       Date:  2013-01-24       Impact factor: 23.472

Review 5.  Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?

Authors:  Vanesa C Sanchez; Jodie R Pietruska; Nathan R Miselis; Robert H Hurt; Agnes B Kane
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2009 Sep-Oct

Review 6.  Asbestos-induced lung diseases: an update.

Authors:  David W Kamp
Journal:  Transl Res       Date:  2009-02-11       Impact factor: 7.012

7.  Asbestos bodies count and morphometry in bulk lung tissue samples by non-invasive X-ray micro-tomography.

Authors:  Fabrizio Bardelli; Francesco Brun; Silvana Capella; Donata Bellis; Claudia Cippitelli; Alessia Cedola; Elena Belluso
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

8.  Reply to Mirabelli et al. Is Mesothelioma Unrelated to the Lung Asbestos Burden? Comment on "Visonà et al. Inorganic Fiber Lung Burden in Subjects with Occupational and/or Anthropogenic Environmental Asbestos Exposure in Broni (Pavia, Northern Italy): An SEM-EDS Study on Autoptic Samples. Int. J. Environ. Res. Public Health 2021, 18, 2053".

Authors:  Silvia Damiana Visonà; Silvana Capella; Sofia Bodini; Paola Borrelli; Simona Villani; Eleonora Crespi; Andrea Frontini; Claudio Colosio; Ruggero Vigliaturo; Elena Belluso
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

9.  Bovine lactoferrin ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats.

Authors:  Yasumasa Okazaki; Isato Kono; Takayoshi Kuriki; Satomi Funahashi; Soichiro Fushimi; Mohammad Iqbal; Shigeru Okada; Shinya Toyokuni
Journal:  J Clin Biochem Nutr       Date:  2012-08-04       Impact factor: 3.114

10.  The interaction of asbestos and iron in lung tissue revealed by synchrotron-based scanning X-ray microscopy.

Authors:  Lorella Pascolo; Alessandra Gianoncelli; Giulia Schneider; Murielle Salomé; Manuela Schneider; Carla Calligaro; Maya Kiskinova; Mauro Melato; Clara Rizzardi
Journal:  Sci Rep       Date:  2013-01-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.